Home Team/Scientists>
Latest News
See all news

TEAM

Scientists

CĂ©cile DĂ©jou

Cécile Déjou is engineer in Biotechnology. She worked at Sysdiag (BioRad/CNRS) within the monoclonal antibody platform from 2008 to 2009 and then worked on immunotherapy for rheumatoid arthritis at INSERM U844 in Montpellier from 2009 to 2013. She joined OREGA Biotech in 2013 as research engineer (Montpellier). See Cécile’s publications.

 
Emilie Laprevotte

Emilie Laprevotte, PhD, is Doctor of biology, health and biotechnology. She specialized in cancer immunotherapy and performed translational work within the INSERM U1037 at the Centre de Recherche en Cancérologie of Toulouse from 2007 to 2012. Emilie joined OREGA Biotech in 2013 and is based in Montpellier. See Emilie’s publications.

 
Aurélie Docquier

Aurélie Docquier, PhD, is Doctor of molecular and cellular biology. During her PhD at the INSERM unit 896 within the Institut de Recherche en Cancérologie de Montpellier, she studied the regulation of genes involved in cell cycle progression in breast cancer and the impact of several hormones on estrogen receptors in ovarian cancer. Then, she joined INRA as a postdoc and was then appointed Preclinical Study Director at 4P-Pharma in 2014, a CRO specialized in oncology. Aurélie joined OREGA Biotech in 2016 and is based in Montpellier. See Aurélie’s publications.

 
Marion Lapierre

Marion Lapierre, PhD, is Doctor of Fundamental Bases in Oncology. She studied the implication of emergent molecules on breast cancer within the INSERM U716 at the Institut de Génétique Moléculaire in Paris from 2004 to 2008. Then, she specialized in molecular mechanisms underlying the intestinal tumor progression and performed translational work during its postdoctoral position at the Montpellier Cancer Research Institute from 2008 to 2014. Marion joined OREGA-Biotech in 2014 as a R&D engineer (Montpellier).

 
Stéphanie Cochaud

Stéphanie Cochaud, PhD, is Doctor of molecular and cellular biology. She studied the molecular mechanisms underlying the progression of glioblastoma within the CNRS UMR 6187 of the Pôle Biologie Santé of Poitiers from 2006 to 2009. She did a postdoctoral training on neuronal stem cells in Coïmbra (Portugal) and was teaching assistant at the University of Poitiers from 2010 to 2011 before joining OREGA Biotech in 2011. Stéphanie is based in Paris. See Stephanie’s publications.

 
JĂ©rĂ´me Giustiniani

Jérôme Giustiniani, PhD, is Doctor of immunology. Jérôme performed fundamental research in immuno-oncology at the INSERM U976 from 2001 to 2005 and then at the CRUK/Queen Mary University of London from 2005 to 2008. He is now researcher at the Institut Jean-Godinot (member of the Unicancer network) and at OREGA Biotech (Paris). See Jérôme’s publications.

 
Marion Philippe

Marion Philippe is engineer in Biology. She worked at Biotrial Pharmacology, a contract research organization based in Rennes. She specialized in Oncology and developed in vivo and in vitro preclinical models of glioblastoma from 2013 to 2014. Then, she joined OREGA Biotech as R&D engineer and is localized in Paris.

 
Events
See all events